MedPath

Funded pharmacy vaccination of pregnant women: uptake and views and experiences

Not Applicable
Recruiting
Conditions
Vaccination
Pertussis
Influenza
Pregnancy
Infection - Other infectious diseases
Public Health - Health service research
Reproductive Health and Childbirth - Antenatal care
Registration Number
ACTRN12616001453471
Lead Sponsor
Dr Natalie Gauld
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Female
Target Recruitment
27000
Inclusion Criteria

Women who were pregnant during the observed period, are NZ residents, were eligible for the vaccinations during the study period, and have a surviving fetus beyond 27 weeks.
Note: women will not be enrolled as such for the primary outcome, and data will only be used for women who had the vaccinations and had a surviving fetus beyond 27 weeks. Women will be eligible for the vaccinations if pregnant but if they do not have a surviving fetus beyond 27 weeks will not be included.
For the secondary qualitative research, women will be invited to participate in an interview and only with informed consent will the interview progress.

Exclusion Criteria

Women who deliver before 27 weeks, or who do not deliver a live baby. Women who are not eligible for funded vaccines (e.g. not NZ residents).

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
umber of influenza vaccinations in pregnant women both overall and by delivery location (general practice, hospital, pharmacy). Measured through vaccination data collected in National Immunisation Record and claims data[24 months after 1 Nov 2016 ];Number of pertussis vaccinations in pregnant women both overall and by delivery location (general practice, hospital, pharmacy). Measured through vaccination data collected in National Immunisation Record and claims data[24 months after 1 Nov 2016];Number of influenza and pertussis vaccinations in pregnant women both overall and by delivery location (general practice, hospital, pharmacy). Measured through vaccination data collected in National Immunisation Record and claims data over a 3-3.5 year period[3-3.5 years after the intervention started]
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath